Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems (SDDSs) takes advantage of the unique physiology of tumors (i.e., disordered structure, leaky vasculature, abnormal extracellular matrix (ECM), and limited lymphatic drainage) to deliver anti-cancer drugs with reduce...

Full description

Saved in:
Bibliographic Details
Main Author: AlSawaftah, Nour Majdi (author)
Other Authors: Pitt, William G. (author), Husseini, Ghaleb (author)
Format: article
Published: 2021
Subjects:
Online Access:http://hdl.handle.net/11073/21492
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513443787177984
author AlSawaftah, Nour Majdi
author2 Pitt, William G.
Husseini, Ghaleb
author2_role author
author
author_facet AlSawaftah, Nour Majdi
Pitt, William G.
Husseini, Ghaleb
author_role author
dc.creator.none.fl_str_mv AlSawaftah, Nour Majdi
Pitt, William G.
Husseini, Ghaleb
dc.date.none.fl_str_mv 2021-06-02T12:47:30Z
2021-06-02T12:47:30Z
2021
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv This document is the unedited Author’s version of a Submitted Work that was subsequently accepted for publication in ACS Pharmacology & Translational Science, ©2021 American Chemical Society after peer review. To access the final edited and published work see https://doi.org/10.1021/acsptsci.1c00066
2575-9108
http://hdl.handle.net/11073/21492
10.1021/acsptsci.1c00066
dc.language.none.fl_str_mv en_US
dc.publisher.none.fl_str_mv American Chemical Society
dc.relation.none.fl_str_mv https://doi.org/10.1021/acsptsci.1c00066
dc.subject.none.fl_str_mv Cancer
Nanocarrier
Targeted delivery
Liposomes
Active targeting
Stimulus
dc.title.none.fl_str_mv Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
dc.type.none.fl_str_mv Peer-Reviewed
Preprint
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description The delivery of chemotherapeutics to solid tumors using smart drug delivery systems (SDDSs) takes advantage of the unique physiology of tumors (i.e., disordered structure, leaky vasculature, abnormal extracellular matrix (ECM), and limited lymphatic drainage) to deliver anti-cancer drugs with reduced systemic side effects. Liposomes are the most promising of such SDDSs and have been well investigated for cancer therapy. To improve the specificity, bioavailability and anti-cancer efficacy of liposomes at the diseased sites, other strategies such as targeting ligands and stimulus-sensitive liposomes have been developed. This review highlights relevant surface functionalization techniques and stimuli-mediated drug release for enhanced delivery of anti-cancer agents at tumor sites, with a special focus on dual functionalization and design of multi-stimuli responsive liposomes.
format article
id aus_40cba9901c8d523ff0304208b48510b2
identifier_str_mv This document is the unedited Author’s version of a Submitted Work that was subsequently accepted for publication in ACS Pharmacology & Translational Science, ©2021 American Chemical Society after peer review. To access the final edited and published work see https://doi.org/10.1021/acsptsci.1c00066
2575-9108
10.1021/acsptsci.1c00066
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/21492
publishDate 2021
publisher.none.fl_str_mv American Chemical Society
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer TreatmentAlSawaftah, Nour MajdiPitt, William G.Husseini, GhalebCancerNanocarrierTargeted deliveryLiposomesActive targetingStimulusThe delivery of chemotherapeutics to solid tumors using smart drug delivery systems (SDDSs) takes advantage of the unique physiology of tumors (i.e., disordered structure, leaky vasculature, abnormal extracellular matrix (ECM), and limited lymphatic drainage) to deliver anti-cancer drugs with reduced systemic side effects. Liposomes are the most promising of such SDDSs and have been well investigated for cancer therapy. To improve the specificity, bioavailability and anti-cancer efficacy of liposomes at the diseased sites, other strategies such as targeting ligands and stimulus-sensitive liposomes have been developed. This review highlights relevant surface functionalization techniques and stimuli-mediated drug release for enhanced delivery of anti-cancer agents at tumor sites, with a special focus on dual functionalization and design of multi-stimuli responsive liposomes.American University of SharjahAl-Jalila FoundationAl Qasimi FoundationPatient's Friends Committee-SharjahBiosciences and Bioengineering Research InstituteDana Gas Endowed Chair for Chemical EngineeringAmerican Chemical Society2021-06-02T12:47:30Z2021-06-02T12:47:30Z2021Peer-ReviewedPreprintinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfThis document is the unedited Author’s version of a Submitted Work that was subsequently accepted for publication in ACS Pharmacology & Translational Science, ©2021 American Chemical Society after peer review. To access the final edited and published work see https://doi.org/10.1021/acsptsci.1c000662575-9108http://hdl.handle.net/11073/2149210.1021/acsptsci.1c00066en_UShttps://doi.org/10.1021/acsptsci.1c00066oai:repository.aus.edu:11073/214922024-08-22T12:06:04Z
spellingShingle Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
AlSawaftah, Nour Majdi
Cancer
Nanocarrier
Targeted delivery
Liposomes
Active targeting
Stimulus
status_str publishedVersion
title Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
title_full Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
title_fullStr Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
title_full_unstemmed Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
title_short Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
title_sort Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment
topic Cancer
Nanocarrier
Targeted delivery
Liposomes
Active targeting
Stimulus
url http://hdl.handle.net/11073/21492